KPV
Anti-inflammatory tripeptide.
Mechanism of Action
Regulates NF-kB and T-cell activity.
Key Benefits
- Reduces inflammation
- Wound healing
Common Uses
What to Expect
Onset
Gut anti-inflammatory effects within days; systemic inflammation reduction over 1–2 weeks
Duration
Effects build over the 4–6 week cycle; best results with consistent daily use
What Users Report
- Reduction in gut inflammation symptoms — less bloating, cramping, and digestive discomfort within the first week
- Improved overall digestion and more regular bowel function
- A calming effect on inflammatory conditions; some users with autoimmune issues report relief
- Effects are relatively subtle and gradual — works gently rather than dramatically
- Synergizes well with BPC-157 for comprehensive gut healing
- Some users report improved skin conditions (acne, eczema, rosacea) as systemic inflammation decreases
- Overall sense of reduced 'internal irritation' — less background discomfort
Typical Timeline
Days 1–3: Early gut calming effects for oral dosing. Days 3–7: Bloating and digestive discomfort begin to improve. Weeks 2–4: Systemic anti-inflammatory benefits become noticeable; skin may improve. Weeks 4–6: Full cycle benefits; significant reduction in inflammatory markers and symptoms.
Side Effects
- Minimal
Dosage Protocol
200–500 mcg oral or subcutaneously daily. Cycles: 4–6 weeks for gut health.
Always consult a physician before starting any peptide protocol.
Administration
Oral or injection
FDA Status
Category 2 (potential reclassification 2026)
Stacks Well With
- BPC-157
Tags
Related peptides
BPC-157
Body Protection Compound-157
Synthetic gastric peptide famous for rapid tissue repair.
ARA-290
Cibinetide
Erythropoietin-derived peptide for nerve repair and anti-inflammatory effects.